immunoprecise antibodies (ipa-tsx.v) interview with ceo dr. jennifer bath
Published 4 years ago • 4.7K plays • Length 1:11:55Download video MP4
Download video MP3
Similar videos
-
1:52:49
immunoprecise antibodies (nasdaq: ipa) update with ceo jennifer bath
-
1:32:34
immunoprecise antibodies (nasdaq: ipa) update with ceo jennifer bath
-
7:30
nasdaq interview with ipa ceo, dr. jennifer bath - june 2023
-
40:18
general assembly holdings (tsx.v: ga) interview with ceo ali khan lalani
-
![immunoprecise antibodies - paul andreola [stock picking]](https://i.ytimg.com/vi/axhO6BsAwsA/mqdefault.jpg)
15:54
immunoprecise antibodies - paul andreola [stock picking]
-
6:27
immunoprecise antibodies on an aggressive sales and business development drive
-
11:56
pioneering new osteosarcoma and breast cancer treatments: exclusive interview with os therapies' ceo
-
36:37
california nanotechnology (tsx.v: cno) interview with eric eyerman
-
3:21
interview with qiao - supply chain director (chinese version)
-
22:17
nanofertilizers for sustainable agriculture
-
37:15
firan technology (tsx: ftg) update with ceo brad bourne
-
14:22
immunoprecise (ipa.c) director paul andreola, explains the importance of antibodies (ep 25) fg/jv
-
2:47
ai's role in antibody discovery
-
9:35
paul andreola from smallcap discoveries pitches vitality products (vpi.v)
-
1:26
predicta med | intel ignite tel-aviv
-
0:53
synthetic co-polymer nanodisc enabling near-native membrane protein assays
-
0:42
cultivating a scientific ecosystem
-
1:01
what challenge does pre-existing immunogenicity present for gene therapy? | science in 60 seconds
-
2:20
i am bio podcast explained - let’s get uncomfortable: talking about women’s health
-
0:31
os therapies: transforming cancer treatment with next-generation immunotherapies for osteosarcoma
-
2:28
cop27: the private sector needs to step up, says novozymes ceo
-
1:41
x-factor to help antibiotics regain their spark